Xuantong Zhou

753 total citations
20 papers, 544 citations indexed

About

Xuantong Zhou is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Xuantong Zhou has authored 20 papers receiving a total of 544 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 6 papers in Cancer Research and 5 papers in Oncology. Recurrent topics in Xuantong Zhou's work include Epigenetics and DNA Methylation (3 papers), MicroRNA in disease regulation (3 papers) and RNA modifications and cancer (3 papers). Xuantong Zhou is often cited by papers focused on Epigenetics and DNA Methylation (3 papers), MicroRNA in disease regulation (3 papers) and RNA modifications and cancer (3 papers). Xuantong Zhou collaborates with scholars based in China, United States and Ethiopia. Xuantong Zhou's co-authors include Zhihua Liu, Aiping Luo, Chunying Chen, Jiaming Liu, Fuhui Wang, Huibiao Liu, Mengyu Guo, Jiayang Li, Zhenzhen Wang and Xingfa Gao and has published in prestigious journals such as Advanced Materials, Nature Communications and Oncogene.

In The Last Decade

Xuantong Zhou

19 papers receiving 538 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xuantong Zhou China 9 268 171 153 130 73 20 544
Zhiying Shao China 12 174 0.6× 69 0.4× 117 0.8× 39 0.3× 117 1.6× 38 493
Mauricio Ramírez United States 15 181 0.7× 41 0.2× 189 1.2× 84 0.6× 35 0.5× 19 543
Liyun Shen China 13 249 0.9× 141 0.8× 57 0.4× 25 0.2× 77 1.1× 30 756
Kun Ke China 16 251 0.9× 140 0.8× 100 0.7× 38 0.3× 176 2.4× 39 586
Sushant Tripathy United States 5 196 0.7× 139 0.8× 74 0.5× 32 0.2× 19 0.3× 8 407
Yangmeihui Song China 14 196 0.7× 83 0.5× 153 1.0× 55 0.4× 79 1.1× 27 498
Mihaela Popa Norway 13 195 0.7× 107 0.6× 186 1.2× 85 0.7× 41 0.6× 25 507
Andrew Dang United States 11 185 0.7× 75 0.4× 85 0.6× 81 0.6× 110 1.5× 23 463
Wen‐He Huang China 11 113 0.4× 140 0.8× 248 1.6× 107 0.8× 111 1.5× 25 532
Huichao Zhou China 11 162 0.6× 113 0.7× 269 1.8× 53 0.4× 109 1.5× 22 603

Countries citing papers authored by Xuantong Zhou

Since Specialization
Citations

This map shows the geographic impact of Xuantong Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xuantong Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xuantong Zhou more than expected).

Fields of papers citing papers by Xuantong Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xuantong Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xuantong Zhou. The network helps show where Xuantong Zhou may publish in the future.

Co-authorship network of co-authors of Xuantong Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Xuantong Zhou. A scholar is included among the top collaborators of Xuantong Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xuantong Zhou. Xuantong Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhou, Xuantong, et al.. (2025). The incidence and risk factors of venous thromboembolism in patients with pancreatic cancer: a systematic review and meta-analysis. Journal of Gastrointestinal Oncology. 16(4). 1667–1681.
2.
Liu, Bing, Tao Wei, Xuantong Zhou, et al.. (2025). Multi‑omics analysis identifies different molecular subtypes with unique outcomes in early-stage poorly differentiated lung adenocarcinoma. Molecular Cancer. 24(1). 129–129. 3 indexed citations
3.
Han, Haibo, Xuantong Zhou, Tongyang Gong, et al.. (2025). Integrating Bulk and Single-Cell Transcriptomics with Machine Learning Reveals a Heme Metabolism-Based Panel for Lung Adenocarcinoma Chemotherapy Resistance. International Journal of Molecular Sciences. 26(10). 4685–4685. 1 indexed citations
4.
Zhou, Xuantong, et al.. (2025). Modified Frailty Index Predicts Prognosis in Patients With Gastric Cancer After Gastrectomy: A Systematic Review and Meta‐Analysis. Journal of Surgical Oncology. 132(1). 54–64. 1 indexed citations
5.
Li, Xin, Xuantong Zhou, Wenyan Gao, et al.. (2024). JunD-miR494-CUL3 axis promotes radioresistance and metastasis by facilitating EMT and restraining PD-L1 degradation in esophageal squamous cell carcinoma. Cancer Letters. 587. 216731–216731. 4 indexed citations
6.
Li, Yulong, Bing Liu, Xuantong Zhou, et al.. (2024). Genome-Scale Multimodal Analysis of Cell-Free DNA Whole-Methylome Sequencing for Noninvasive Esophageal Cancer Detection. JCO Precision Oncology. 8(8). e2400111–e2400111. 1 indexed citations
7.
Yang, Qi, Xinyue Li, Xin Li, et al.. (2024). Targeting ABCA1 via Extracellular Vesicle‐Encapsulated Staurosporine as a Therapeutic Strategy to Enhance Radiosensitivity. Advanced Healthcare Materials. 13(16). e2400381–e2400381. 3 indexed citations
8.
Wang, Xinyi, et al.. (2023). Engineering natural molecule-triggered genetic control systems for tunable gene- and cell-based therapies. Synthetic and Systems Biotechnology. 8(3). 416–426. 1 indexed citations
9.
Zhou, Xuantong, Feng Gao, Minjie Wang, et al.. (2023). MiR-423-5p is a novel endogenous control for the quantification of circulating miRNAs in human esophageal squamous cell carcinoma. Heliyon. 9(4). e14515–e14515. 3 indexed citations
10.
Zhou, Xuantong, et al.. (2022). Dysregulated ceramides metabolism by fatty acid 2-hydroxylase exposes a metabolic vulnerability to target cancer metastasis. Signal Transduction and Targeted Therapy. 7(1). 370–370. 32 indexed citations
11.
Miyoshi, Jinsei, Zhongxu Zhu, Aiping Luo, et al.. (2022). A microRNA-based liquid biopsy signature for the early detection of esophageal squamous cell carcinoma: a retrospective, prospective and multicenter study. Molecular Cancer. 21(1). 44–44. 52 indexed citations
12.
Wu, Xin, Meiyan Wang, Zhilin Hu, et al.. (2022). Optogenetic-controlled immunotherapeutic designer cells for post-surgical cancer immunotherapy. Nature Communications. 13(1). 6357–6357. 40 indexed citations
13.
Li, Yuqing, Yanan Zhang, Qi Yang, et al.. (2022). Silencing of FANCI Promotes DNA Damage and Sensitizes OvarianCancer Cells to Carboplatin. Current Cancer Drug Targets. 22(7). 591–602. 5 indexed citations
14.
Chen, Li, Xuantong Zhou, Xiangyi Kong, et al.. (2021). The Prognostic Significance of Anisomycin-Activated Phospho-c-Jun NH2-Terminal Kinase (p-JNK) in Predicting Breast Cancer Patients’ Survival Time. Frontiers in Cell and Developmental Biology. 9. 656693–656693. 9 indexed citations
15.
Zhou, Xuantong, Min You, Fuhui Wang, et al.. (2021). Multifunctional Graphdiyne–Cerium Oxide Nanozymes Facilitate MicroRNA Delivery and Attenuate Tumor Hypoxia for Highly Efficient Radiotherapy of Esophageal Cancer. Advanced Materials. 33(24). e2100556–e2100556. 192 indexed citations
16.
Huang, Furong, Gang Ma, Xuantong Zhou, et al.. (2020). Depletion of LAMP3 enhances PKA-mediated VASP phosphorylation to suppress invasion and metastasis in esophageal squamous cell carcinoma. Cancer Letters. 479. 100–111. 19 indexed citations
17.
Luo, Aiping, Xuantong Zhou, Xing Shi, et al.. (2019). Exosome-derived miR-339-5p mediates radiosensitivity by targeting Cdc25A in locally advanced esophageal squamous cell carcinoma. Oncogene. 38(25). 4990–5006. 108 indexed citations
18.
Ren, Jie, Qiugang Zong, Xuantong Zhou, R. Rankin, & Y. F. Wang. (2016). Interaction of ULF waves with different ion species: Pitch angle and phase space density implications. Journal of Geophysical Research Space Physics. 121(10). 9459–9472. 31 indexed citations
19.
Yu, Jing, Ning Li, Xin Wang, et al.. (2016). Circulating serum microRNA-345 correlates with unfavorable pathological response to preoperative chemoradiotherapy in locally advanced rectal cancer. Oncotarget. 7(39). 64233–64243. 38 indexed citations
20.
Song, P., V. M. Vasyliūnas, & Xuantong Zhou. (2007). Magnetosphere-Ionosphere/thermosphere Coupling: Self-consistent Solutions for a 1-D Stratified Ionosphere in 3-fluid Theory. AGU Fall Meeting Abstracts. 2007. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zhiying Shao Breakdown of academic impact, for papers by Mauricio Ramírez Breakdown of academic impact, for papers by Liyun Shen Breakdown of academic impact, for papers by Kun Ke Breakdown of academic impact, for papers by Sushant Tripathy Breakdown of academic impact, for papers by Yangmeihui Song Breakdown of academic impact, for papers by Mihaela Popa Breakdown of academic impact, for papers by Andrew Dang Breakdown of academic impact, for papers by Wen‐He Huang Breakdown of academic impact, for papers by Huichao Zhou
Rankless by CCL
2026